Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2003
06/26/2003CA2470763A1 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470322A1 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470060A1 Improvements in pharmaceutical compositions
06/26/2003CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003CA2469976A1 Improvements in pharmaceutical compositions
06/26/2003CA2469786A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003CA2468790A1 Chemokine mutants acting as chemokine antagonists
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320552A1 Method for producing human anti-thymocyte immunoglobulins
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320547A1 Transfer factor from birds eggs
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320532A1 Tetrapyrroles
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320381A1 New immunogenic complex
06/25/2003EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/25/2003EP1283725A4 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP0932411B1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0679182B1 Delivery of gene products via mesangial cells
06/25/2003CN1426472A Nucleic acid construct encoding processing component derived from N-terminal region of hepatitis virus ORF2, and an antigenic polypeptide
06/25/2003CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1426461A Method of producing membrane vesicles
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426411A 3-(diarylmethylene)-8-azabicyclo [3,2,1] octane derivatives
06/25/2003CN1426409A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426309A Adjuvanted genetic vaccines
06/25/2003CN1426304A Chemical Modification of mammalian urine and blood
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583283 Polymorphic forms of cipamfylline
06/24/2003US6583265 Cyclosporins
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583146 Thiazolopyrimidine compounds, its production and use
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583129 Administration of non-oral androgenic steroids to women
06/24/2003US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders
06/24/2003US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids
06/24/2003US6582728 On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs
06/24/2003US6582721 Stable carotene-xanthophyll beadlet compositions and methods of use
06/24/2003US6582718 Topical, ophthalmic cyclosporin A formulation having better distribution due to surfactant (polyoxyethylene fatty acid esters) causing less irritation to the eyes
06/24/2003US6582694 Method for preparing a viral aerosol
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/24/2003CA2276405C Benzimidazole derivatives and pharmacologically acceptable salts thereof
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/24/2003CA1341433C Purification of interleukin 1
06/19/2003WO2003050499A2 Use of a labeled ligand having human cd4 specificity
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050251A2 Hematopoietic cells from human embryonic stem cells
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049783A2 Device and methods for harvesting tissue samples of known geometry
06/19/2003WO2003049769A2 Method for reducing acne or improving skin tone
06/19/2003WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049727A1 Treatment of neoplasia
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049682A2 Composition and method for treating chronic allograft rejection
06/19/2003WO2003049680A2 Compositions containing both sedative and non-sedative antihistamines
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049626A1 Method and apparatus for production of a skin graft and the graft produced thereby
06/19/2003WO2003013438A3 Nutrient therapy for immuno-compromised patients
06/19/2003WO2003009777A3 Delivery of therapeutic capable agents
06/19/2003WO2003005960A3 Novel bicyclic and tricyclic cannabinoids
06/19/2003WO2002088172B1 Pentapeptide compounds and uses related thereto
06/19/2003WO2002077237A3 Transporters and ion channels
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 1172